Oxidative stress and hepatitis C virus
详细信息 查看全文
- 作者：Usman Zafar Paracha (1)
Kaneez Fatima (2)
Mohammad Alqahtani (3)
Adeel Chaudhary (3) (5)
Adel Abuzenadah (4) (5)
Ghazi Damanhouri (5)
Ishtiaq Qadri (5) - 关键词：Oxidative stress ; ROS ; HCV
- 刊名：Virology Journal
- 出版年：2013
- 出版时间：December 2013
- 年：2013
- 卷：10
- 期：1
- 全文大小：495KB
- 参考文献：1. Qadri I, Iwahashi M, Capasso JM, Hopken MW, Flores S, Schaack J, Simon FR: Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: role of JNK, p38 MAPK and AP-1. / Biochem J 2004,378(Pt 3):919-28. CrossRef
2. Jones DP: Redefining oxidative stress. / Antioxid Redox Signal 2006,8(9-0):1865-879. CrossRef
3. Gloire G, Legrand-Poels S, Piette J: NF-kappaB activation by reactive oxygen species: fifteen years later. / Biochem Pharmacol 2006,72(11):1493-505. CrossRef
4. Lander HM: An essential role for free radicals and derived species in signal transduction. / FASEB J 1997,11(2):118-24.
5. Devadas S, Zaritskaya L, Rhee SG, Oberley L, Williams MS: Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. / J Exp Med 2002,195(1):59-0. CrossRef
6. Hildeman DA: Regulation of T-cell apoptosis by reactive oxygen species. / Free Radic Biol Med 2004,36(12):1496-504. CrossRef
7. Sen CK, Sies H, Baeuerle PA: Antioxidant and redox regulation of genes. / Academic Press 2000.
8. Mittler R, Vanderauwera S, Suzuki N, Miller G, Tognetti VB, Vandepoele K, Gollery M, Shulaev V, Van Breusegem F: ROS signaling: the new wave? / Trends Plant Sci 2011,16(6):300-09. CrossRef
9. Go YM, Jones DP: Redox compartmentalization in eukaryotic cells. / Biochim Biophys Acta 2008,1780(11):1273-290. CrossRef
10. Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, Choi AM: Mechanisms of cell death in oxidative stress. / Antioxid Redox Signal 2007,9(1):49-9. CrossRef
11. Desikan R, Hancock J, Neill S: Reactive Oxygen Species as Signalling Molecules. In / Antioxidants and Reactive Oxygen Species in Plants. Oxford, UK: Blackwell Publishing Ltd; 2007:169-96. CrossRef
12. Yamada S, Nomoto S, Fujii T, Kaneko T, Takeda S, Inoue S, Kanazumi N, Nakao A: Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma. / Eur J Surg Oncol 2006,32(3):303-07. CrossRef
13. Yen HH, Shih KL, Lin TT, Su WW, Soon MS, Liu CS: Decreased mitochondrial deoxyribonucleic acid and increased oxidative damage in chronic hepatitis C. / World J Gastroenterol 2012,18(36):5084-089. CrossRef
14. Okochi O, Hibi K, Uemura T, Inoue S, Takeda S, Kaneko T, Nakao A: Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. / Clin Cancer Res 2002,8(9):2875-878.
15. Liu CS, Tsai CS, Kuo CL, Chen HW, Lii CK, Ma YS, Wei YH: Oxidative stress-related alteration of the copy number of mitochondrial DNA in human leukocytes. / Free Radic Res 2003,37(12):1307-317. CrossRef
16. Kim JY, Hwang JM, Ko HS, Seong MW, Park BJ, Park SS: Mitochondrial DNA content is decreased in autosomal dominant optic atrophy. / Neurology 2005,64(6):966-72. CrossRef
17. De Mendoza C, Soriano V: The role of hepatitis C virus (HCV) in mitochondrial DNA damage in HIV/HCV-coinfected individuals. / Antivir Ther 2005,10(Suppl 2):M109-M115.
18. Fujinaga H, Tsutsumi T, Yotsuyanagi H, Moriya K, Koike K: Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species. / Oncology 2011,81(Suppl 1):11-7. CrossRef
19. Malhotra JD, Kaufman RJ: Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? / Antioxid Redox Signal 2007,9(12):2277-293. CrossRef
20. Berridge MJ, Bootman MD, Roderick HL: Calcium signalling: dynamics, homeostasis and remodelling. / Nat Rev Mol Cell Biol 2003,4(7):517-29. CrossRef
21. G?rlach A, Klappa P, Kietzmann T: The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. / Antioxid Redox Signal 2006,8(9-0):1391-418. CrossRef
22. Lizák B, Czegle I, Csala M, Benedetti A, Mandl J, Bánhegyi G: Translocon pores in the endoplasmic reticulum are permeable to small anions. / Am J Physiol Cell Physiol 2006,291(3):C511-C517. CrossRef
23. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. / Science 1989,244(4902):359-62. CrossRef
24. Simmonds P: Genetic diversity and evolution of hepatitis C virus--15 years on. / J Gen Virol 2004,85(Pt11):3173-188. CrossRef
25. WHO: / Hepatitis C. http://www.who.int/mediacentre/factsheets/fs164/en/
26. Ivanov AV, Bartosch B, Smirnova OA, Isaguliants MG, Kochetkov SN: HCV and Oxidative Stress in the Liver. / Viruses 2013,5(2):439-69. CrossRef
27. Bhargava A, Raghuram GV, Pathak N, Varshney S, Jatawa SK, Jain D, Mishra PK: Occult hepatitis C virus elicits mitochondrial oxidative stress in lymphocytes and triggers PI3-kinase-mediated DNA damage response. / Free Radic Biol Med 2011,51(9):1806-814. CrossRef
28. Muriel P: Role of free radicals in liver diseases. / Hepatol Int 2009,3(4):526-36. CrossRef
29. García-Monzón C, Majano PL, Zubia I, Sanz P, Apolinario A, Moreno-Otero R: Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. / J Hepatol 2000,32(2):331-38. CrossRef
30. Farinati F, Cardin R, De Maria N, Della Libera G, Marafin C, Lecis E, Burra P, Floreani A, Cecchetto A, Naccarato R: Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. / J Hepatol 1995,22(4):449-56. CrossRef
31. Rosen HR, Gretch DR: Hepatitis C virus: current understanding and prospects for future therapies. / Mol Med Today 1999,5(9):393-99. CrossRef
32. Valgimigli M, Valgimigli L, Trerè D, Gaiani S, Pedulli GF, Gramantieri L, Bolondi L: Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation. / Free Radic Res 2002,36(9):939-48. CrossRef
33. Valgimigli L, Valgimigli M, Gaiani S, Pedulli GF, Bolondi L: Measurement of oxidative stress in human liver by EPR spin-probe technique. / Free Radic Res 2000,33(2):167-78. CrossRef
34. Jenny-Avital ER: Hepatitis C. / Curr Opin Infect Dis 1998,11(3):293-99. CrossRef
35. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, / et al.: Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. / Proc Natl Acad Sci U S A 1990,87(17):6547-549. CrossRef
36. Barbaro G, Di Lorenzo G, Asti A, Ribersani M, Belloni G, Grisorio B, Filice G, Barbarini G: Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. / Am J Gastroenterol 1999,94(8):2198-205. CrossRef
37. Forns X, Purcell RH, Bukh J: Quasispecies in viral persistence and pathogenesis of hepatitis C virus. / Trends Microbiol 1999,7(10):402-10. CrossRef
38. Koike K: Hepatitis C virus contributes to hepatocarcinogenesis by modulating metabolic and intracellular signaling pathways. / J Gastroenterol Hepatol 2007,22(Suppl 1):S108-S111. CrossRef
39. Ivanov AV, Smirnova OA, Ivanova ON, Masalova OV, Kochetkov SN, Isaguliants MG: Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells. / PLoS One 2011,6(9):e24957. CrossRef
40. Pal S, Polyak SJ, Bano N, Qiu WC, Carithers RL, Shuhart M, Gretch DR, Das A: Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1. / J Gastroenterol Hepatol 2010,25(3):627-34. CrossRef
41. Bureau C, Bernad J, Chaouche N, Orfila C, Béraud M, Gonindard C, Alric L, Vinel JP, Pipy B: Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. / J Biol Chem 2001,276(25):23077-3083. CrossRef
42. García-Mediavilla MV, Sánchez-Campos S, González-Pérez P, Gómez-Gonzalo M, Majano PL, López-Cabrera M, Clemente G, García-Monzón C, González-Gallego J: Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocyte-derived cells. / J Hepatol 2005,43(4):606-13. CrossRef
43. Thorén F, Romero A, Lindh M, Dahlgren C, Hellstrand K: A hepatitis C virus-encoded, nonstructural protein (NS3) triggers dysfunction and apoptosis in lymphocytes: role of NADPH oxidase-derived oxygen radicals. / J Leukoc Biol 2004,76(6):1180-186. CrossRef
44. Ming-Ju H, Yih-Shou H, Tzy-Yen C, Hui-Ling C: Hepatitis C virus E2 protein induce reactive oxygen species (ROS)-related fibrogenesis in the HSC-T6 hepatic stellate cell line. / J Cell Biochem 2011,112(1):233-43. CrossRef
45. Li S, Ye L, Yu X, Xu B, Li K, Zhu X, Liu H, Wu X, Kong L: Hepatitis C virus NS4B induces unfolded protein response and endoplasmic reticulum overload response-dependent NF-kappaB activation. / Virology 2009,391(2):257-64. CrossRef
46. Liang Y, Ye H, Kang CB, Yoon HS: Domain 2 of Nonstructural Protein 5A (NS5A) of Hepatitis C Virus Is Natively Unfolded. / Biochemistry 2007,46(41):11550-1558. CrossRef
47. Piccoli C, Quarato G, Ripoli M, D’Aprile A, Scrima R, Cela O, Boffoli D, Moradpour D, Capitanio N: Review HCV infection induces mitochondrial bioenergetic unbalance: causes and effects. / Biochim Biophys Acta 2009,1787(5):539-46. CrossRef
48. Piccoli C, Scrima R, D'Aprile A, Ripoli M, Lecce L, Boffoli D, Capitanio N: Review Mitochondrial dysfunction in hepatitis C virus infection. / Biochim Biophys Acta 2006,1757(9-0):1429-437.
49. Gong G, Waris G, Tanveer R, Siddiqui A: Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. / Proc Natl Acad Sci U S A 2001,98(17):9599-604. CrossRef
50. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA: Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. / Gastroenterology 2002,122(2):366-75. CrossRef
51. Jaiswal M, LaRusso NF, Shapiro RA, Billiar TR, Gores GJ: Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. / Gastroenterology 2001,120(1):190-99. CrossRef
52. Machida K, McNamara G, Cheng KT, Huang J, Wang CH, Comai L, Ou JH, Lai MM: Hepatitis C virus inhibits DNA damage repair through reactive oxygen and nitrogen species and by interfering with the ATM-NBS1/Mre11/Rad50 DNA repair pathway in monocytes and hepatocytes. / J Immunol 2010,185(11):6985-998. CrossRef
53. Machida K, Tsukamoto H, Liu JC, Han YP, Govindarajan S, Lai MM, Akira S, Ou JH: c-Jun mediates hepatitis C virus hepatocarcinogenesis through signal transducer and activator of transcription 3 and nitric oxide-dependent impairment of oxidative DNA repair. / Hepatology 2010,52(2):480-92. CrossRef
54. Zhu Z, Wilson AT, Mathahs MM, Wen F, Brown KE, Luxon BA, Schmidt WN: Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injury. / Hepatology 2008,48(5):1430-439. CrossRef
55. Sumida Y, Nakashima T, Yoh T, Nakajima Y, Ishikawa H, Mitsuyoshi H, Sakamoto Y, Okanoue T, Kashima K, Nakamura H, Yodoi J: Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. / J Hepatol 2000,33(4):616-22. CrossRef
56. Nakashima T, Sumida Y, Yoh T, Kakisaka Y, Nakajima Y, Ishikawa H, Mitsuyoshi H, Kashima K, Nakamura H, Yodoi J: Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with glycyrrhizin or ursodeoxycholic acid. / Antioxid Redox Signal 2000,2(4):687-94. CrossRef
57. Levent G, Ali A, Ahmet A, Polat EC, Ayta? C, Ay?e E, Ahmet S: Oxidative stress and antioxidant defense in patients with chronic hepatitis C patients before and after pegylated interferon alfa-2b plus ribavirin therapy. / J Transl Med 2006, 4:25. CrossRef
58. Osman HG, Gabr OM, Lotfy S, Gabr S: Serum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitis. / Indian J Med Microbiol 2007,25(4):323-29. CrossRef
59. Tsukiyama-Kohara K: Role of Oxidative Stress in Hepatocarcinogenesis Induced by Hepatitis C Virus. / Int J Mol Sci 2012,13(11):15271-5278. CrossRef
60. Boudreau HE, Emerson SU, Korzeniowska A, Jendrysik MA, Leto TL: Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stress. / J Virol 2009,83(24):12934-2946. CrossRef
61. Choi J, Ou JH: Review Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. / Am J Physiol Gastrointest Liver Physiol 2006,290(5):G847-G851. CrossRef
62. Jain SK, Pemberton PW, Smith A, McMahon RF, Burrows PC, Aboutwerat A, Warnes TW: Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. / J Hepatol 2002,36(6):805-11. CrossRef
63. Weinreb O, Amit T, Mandel S, Kupershmidt L, Youdim MB: Neuroprotective multifunctional iron chelators: from redox-sensitive process to novel therapeutic opportunities. / Antioxid Redox Signal 2010,13(6):919-49. CrossRef
64. Ganz T, Nemeth E: Hepcidin and iron homeostasis. / Biochim Biophys Acta 2012,1823(9):1434-443. CrossRef
65. Andrews NC: Iron homeostasis: insights from genetics and animal models. / Nat Rev Genet 2000,1(3):208-17. CrossRef
66. Pantopoulos K, Porwal SK, Tartakoff A, Devireddy L: Mechanisms of mammalian iron homeostasis. / Biochemistry 2012,51(29):5705-724. CrossRef
67. Riggio O, Montagnese F, Fiore P, Folino S, Giambartolomei S, Gandin C, Merli M, Quinti I, Violante N, Caroli S, Senofonte O, Capocaccia L: Iron overload in patients with chronic viral hepatitis: how common is it? / Am J Gastroenterol 1997,92(8):1298-301.
68. Kaito M, Iwasa M, Kobayashi Y, Fujita N, Tanaka H, Gabazza EC, Adachi Y, Kojima Y, Nakagawa N, Watanabe S: Iron reduction therapy by phlebotomy reduces lipid peroxidation and oxidative stress in patients with chronic hepatitis C. / J Gastroenterol 2006,41(9):921-22. CrossRef
69. Fujita N, Horiike S, Sugimoto R, Tanaka H, Iwasa M, Kobayashi Y, Hasegawa K, Ma N, Kawanishi S, Adachi Y, Kaito M: Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients. / Free Radic Biol Med 2007,42(3):353-62. CrossRef
70. Smirnova OA, Ivanov AV, Ivanova ON, Valuev-éllison VT, Kochetkov SN: Cellular defense systems against oxidative and ER stresses: mechanisms of regulation and influence of hepatitis C virus. / Mol Biol (Mosk) 2011,45(1):127-41. CrossRef
71. Aleksunes LM, Manautou JE: Emerging role of Nrf2 in protecting against hepatic and gastrointestinal disease. / Toxicol Pathol 2007,35(4):459-73. CrossRef
72. Yuan L, Kaplowitz N: Glutathione in liver diseases and hepatotoxicity. / Mol Aspects Med 2009,30(1-):29-1. CrossRef
73. Morgan B, Ezeri?a D, Amoako TN, Riemer J, Seedorf M, Dick TP: Multiple glutathione disulfide removal pathways mediate cytosolic redox homeostasis. / Nat Chem Biol 2012,9(2):119-25. CrossRef
74. Aggarwal A, Misro MM, Maheshwari A, Sehgal N, Nandan D: N-acetylcysteine counteracts oxidative stress and prevents hCG-induced apoptosis in rat Leydig cells through down regulation of caspase-8 and JNK. / Mol Reprod Dev 2010,77(10):900-09. CrossRef
75. Kerksick C, Willoughby D: The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. / J Int Soc Sports Nutr 2005, 2:38-4. CrossRef
76. Pickering AM, Linder RA, Zhang H, Forman HJ, Davies KJ: Nrf2-dependent Induction of Proteasome and Pa28 Regulator Are Required for Adaptation to Oxidative Stress. / J Biol Chem 2012,287(13):10021-0031. CrossRef
77. Hochmuth CE, Biteau B, Bohmann D, Jasper H: Redox Regulation by Keap1 and Nrf2 Controls Intestinal Stem Cell Proliferation in Drosophila . / Cell Stem Cell 2011,8(2):188-99. CrossRef
78. Barajas B, Che N, Yin F, Rowshanrad A, Orozco LD, Gong KW, Wang X, Castellani LW, Reue K, Lusis AJ, Araujo JA: NF-E2–Related Factor 2 Promotes Atherosclerosis by Effects on Plasma Lipoproteins and Cholesterol Transport That Overshadow Antioxidant Protection. / Arterioscler Thromb Vasc Biol 2011,31(1):58-6. CrossRef
79. Burdette D, Olivarez M, Waris G: Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. / J Gen Virol 2010,91(Pt 3):681-90. CrossRef
80. Kitada T, Seki S, Iwai S, Yamada T, Sakaguchi H, Wakasa K: In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. / J Hepatol 2001,35(5):613-18. CrossRef
81. Carvajal-Yepes M, Himmelsbach K, Schaedler S, Ploen D, Krause J, Ludwig L, Weiss T, Klingel K, Hildt E: Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins. / J Biol Chem 2011,286(11):8941-951. CrossRef
82. Weismann D, Hartvigsen K, Lauer N, Bennett KL, Scholl HP, Charbel Issa P, Cano M, Brandst?tter H, Tsimikas S, Skerka C, Superti-Furga G, Handa JT, Zipfel PF, Witztum JL, Binder CJ: Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. / Nature 2011,478(7367):76-1. CrossRef
83. Qadri I, Iwahashi M, Kullak-Ublick GA, Simon FR: Hepatocyte nuclear factor (HNF) 1 and HNF4 mediate hepatic multidrug resistance protein 2 up-regulation during hepatitis C virus gene expression. / Mol Pharmacol 2006,70(2):627-36. CrossRef
84. Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, Seluanov A, Gorbunova V: SIRT6 Promotes DNA Repair Under Stress by Activating PARP1. / Science 2011,332(6036):1443-446. CrossRef
85. Berkson BM: A conservative triple antioxidant approach to the treatment of hepatitis C. Combination of alpha lipoic acid (thioctic acid), silymarin, and selenium: three case histories. / Med Klin (Munich) 1999, 94:84-9. CrossRef
86. Bilska A, W?odek L: Lipoic acid - the drug of the future? / Pharmacol Rep 2005,57(5):570-77.
87. Syed GH, Siddiqui A: Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus. / Hepatology 2011,54(6):1936-946. CrossRef
88. Emerit J, Samuel D, Pavio N: Cu-Zn super oxide dismutase as a potential antifibrotic drug for hepatitis C related fibrosis. / Biomed Pharmacother 2006,60(1):1-. CrossRef
89. Tai DI, Tsai SL, Chen YM, Chuang YL, Peng CY, Sheen IS, Yeh CT, Chang KS, Huang SN, Kuo GC, Liaw YF: Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis. / Hepatology 2000,31(3):656-64. CrossRef
90. Gane EJ, Weilert F, Orr DW, Keogh GF, Gibson M, Lockhart MM, Frampton CM, Taylor KM, Smith RA, Murphy MP: The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. / Liver Int 2010,30(7):1019-026. CrossRef
91. Bartosch B: HCV and Liver Carbohydrate Metabolism . In / 7th Annual Meeting the New Visby University Network on Hepatitis C, Tartu, Estonia: February 20-3, 2010 Edited by: Isaguliants MG. 2010.
92. Marcus NY, Blomenkamp K, Ahmad M, Teckman JH: Oxidative stress contributes to liver damage in a murine model of alpha-1-antitrypsin deficiency. / Exp Biol Med (Maywood) 2012,237(10):1163-172. CrossRef - 作者单位：Usman Zafar Paracha (1)
Kaneez Fatima (2)
Mohammad Alqahtani (3)
Adeel Chaudhary (3) (5)
Adel Abuzenadah (4) (5)
Ghazi Damanhouri (5)
Ishtiaq Qadri (5)
1. Department of Pharmaceutics, Hajvery University, Lahore, Pakistan
2. IQ Institute of Infection and Immunity, Lahore, Punjab, Pakistan
3. Center of Excellence in Genomic Medicine, King Abdul Aziz University, PO Box 80216, Jeddah, 21589, Saudi Arabia
5. King Fahd Medical Research Center, King Abdul Aziz University, PO Box 80216, Jeddah, 21589, Saudi Arabia
4. Faculty of Applied Medical Sciences, King Abdulaziz University, PO Box 80216, Jeddah, 21589, Saudi Arabia - ISSN：1743-422X
文摘
The disproportionate imbalance between the systemic manifestation of reactive oxygen species and body’s ability to detoxify the reactive intermediates is referred to as oxidative stress. Several biological processes as well as infectious agents, physiological or environmental stress, and perturbed antioxidant response can promote oxidative stress. Oxidative stress usually happens when cells are exposed to more electrically charged reactive oxygen species (ROS) such as H2O2 or O2-. The cells-ability to handle such pro-oxidant species is impeded by viral infections particularly within liver that plays an important role in metabolism and detoxification of harmful substances. During liver diseases (such as hepatocellular or cholestatic problems), the produced ROS are involved in transcriptional activation of a large number of cytokines and growth factors, and continued production of ROS and Reactive Nitrogen Species (RNS) feed into the vicious cycle. Many human viruses like HCV are evolved to manipulate this delicate pro- and antioxidant balance; thus generating the sustainable oxidative stress that not only causes hepatic damage but also stimulates the processes to reduce treatment of damage. In this review article, the oxidant and antioxidant pathways that are perturbed by HCV genes are discussed. In the first line of risk, the pathways of lipid metabolism present a clear danger in accumulation of viral induced ROS. Viral infection leads to decrease in cellular concentrations of glutathione (GSH) resulting in oxidation of important components of cells such as proteins, DNA and lipids as well as double strand breakage of DNA. These disorders have the tendency to lead the cells toward cirrhosis and hepatocellular carcinoma in adults due to constant insult. We have highlighted the importance of such pathways and revealed differences in the extent of oxidative stress caused by HCV infection.